Summit Therapeutics (SMMT) Metrics: History & Chart

Summit Therapeutics Inc.(SMMT)

Biotechnology · Miami, FL

$17.31+0.04 (+0.23%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Summit Therapeutics Inc.

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Miami, FL

265 employees

www.smmttx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert W. Duggan

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+11.56%
30D Total Return	-1.93%
YTD Total Return	-1.26%
1Y Total Return	-19.41%
3Y Total Return	+854.12%
5Y Total Return	+244.75%
10Y Total Return	+20.35%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-1.26%
2025	-2.02%
2024	+583.91%
2023	-38.59%
2022	+57.99%
2021	-42.77%
2020

CAGR TTM	-19.33%
CAGR 3Y	+112.06%
CAGR 5Y	+28.09%
CAGR 10Y	+1.87%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	11.30
PE Ratio Avg TTM	34.37
PE Ratio Avg 3Y	34.37
Current VS TTM Avg	-67.13%
Current VS 3Y Avg	-67.13%
Current VS 5Y Avg	-67.13%

All Metrics

SMMT Valuation Metrics

SMMT Stock Price Metrics

SMMT Dividend Metrics

SMMT Growth Rate Metrics

SMMT Discounted Cash Flow Metrics

SMMT Returns By Period

SMMT Yearly Returns

SMMT Average Annual Returns By Period (CAGR)

SMMT Revenue Metrics

SMMT PE Ratio Metrics

SMMT PS Ratio Metrics

SMMT PB Ratio Metrics

SMMT Price to Free Cash Flow Ratio Metrics

SMMT Debt to Equity Ratio Metrics

SMMT PEG Ratio Metrics

SMMT FCF Yield

SMMT Earnings Yield

SMMT EBITDA Yield

SMMT OCF Yield

SMMT EV/EBIT Ratio Metrics

SMMT EV/EBITDA Ratio Metrics

SMMT EV/Assets Ratio Metrics

SMMT EV/Sales Ratio Metrics

SMMT Current Ratio Metrics

SMMT Quick Ratio Metrics

SMMT ROIC Metrics

SMMT Return on Assets Metrics

SMMT Return on Equity Metrics

SMMT Net Profit Margin Metrics

SMMT Gross Profit Margin Metrics

SMMT Tax Rate Metrics

PS Ratio	6781.82
PS Ratio Avg TTM	2369.45
PS Ratio Avg 3Y	647.43
Current VS TTM Avg	+186.22%
Current VS 3Y Avg	+947.50%
Current VS 5Y Avg	+1564.61%

PB Ratio	21.33
PB Ratio Avg TTM	42.40
PB Ratio Avg 3Y	49.96
Current VS TTM Avg	-49.70%
Current VS 3Y Avg	-57.30%
Current VS 5Y Avg	-31.22%

PFCF Ratio	17.71
PFCF Ratio Avg TTM	39.80
PFCF Ratio Avg 3Y	39.80
Current VS TTM Avg	-55.50%
Current VS 3Y Avg	-55.50%
Current VS 5Y Avg	-55.50%

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.35
Current VS TTM Avg	+7.57%
Current VS 3Y Avg	-90.65%
Current VS 5Y Avg	-89.75%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	5.65%
FCF Yield Avg TTM	2.87%
FCF Yield Avg 3Y	2.87%
Current VS TTM Avg	+96.57%
Current VS 3Y Avg	+96.57%
Current VS 5Y Avg	+96.57%

Earnings Yield	8.85%
Earnings Yield Avg TTM	4.63%
Earnings Yield Avg 3Y	4.63%
Current VS TTM Avg	+91.08%
Current VS 3Y Avg	+91.08%
Current VS 5Y Avg	+91.08%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	5.39
Ev/Ebit Ratio Avg TTM	11.45
Ev/Ebit Ratio Avg 3Y	11.45
Current VS TTM Avg	-52.92%
Current VS 3Y Avg	-52.92%
Current VS 5Y Avg	-52.92%

Ev/Ebitda Ratio	5.06
Ev/Ebitda Ratio Avg TTM	36.50
Ev/Ebitda Ratio Avg 3Y	36.50
Current VS TTM Avg	-86.14%
Current VS 3Y Avg	-86.14%
Current VS 5Y Avg	-86.14%

Ev/Assets Ratio	17.34
Ev/Assets Ratio Avg TTM	34.25
Ev/Assets Ratio Avg 3Y	36.64
Current VS TTM Avg	-49.37%
Current VS 3Y Avg	-52.67%
Current VS 5Y Avg	-24.53%

Ev/Sales Ratio	7042.86
Ev/Sales Ratio Avg TTM	2479.42
Ev/Sales Ratio Avg 3Y	603.16
Current VS TTM Avg	+184.05%
Current VS 3Y Avg	+1067.66%
Current VS 5Y Avg	+1695.07%

Current Ratio	6.96
Current Ratio Avg TTM	6.63
Current Ratio Avg 3Y	6.89
Current VS TTM Avg	+4.93%
Current VS 3Y Avg	+1.01%
Current VS 5Y Avg	-4.34%

Quick Ratio	6.96
Quick Ratio Avg TTM	6.63
Quick Ratio Avg 3Y	6.89
Current VS TTM Avg	+4.93%
Current VS 3Y Avg	+1.01%
Current VS 5Y Avg	-4.34%

ROIC	(134.14%)
ROIC Avg 3Y	(197.53%)
ROIC Avg 5Y	(156.81%)
Current VS 3Y Avg	+32.09%
Current VS 5Y Avg	+14.46%
Current VS 10Y Avg	-33.11%

ROA	(113.81%)
ROA Avg TTM	(79.81%)
ROA Avg 3Y	(20.35%)
Current VS TTM Avg	-42.61%
Current VS 3Y Avg	-459.29%
Current VS 5Y Avg	-516.82%

ROE	(135.89%)
ROE Avg TTM	(277.06%)
ROE Avg 3Y	(293.79%)
Current VS TTM Avg	+50.95%
Current VS 3Y Avg	+53.75%
Current VS 5Y Avg	+33.97%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	+100.00%

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

Tax Rate	1.81%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A